Modulation of SPARC/Hevin Proteins in Alzheimer's Disease Brain Injury.

Alzheimer's disease (AD) is an age-related progressive form of dementia that features neuronal loss, intracellular tau, and extracellular amyloid-β (Aβ) protein deposition. Neurodegeneration is accompanied by neuroinflammation mainly involving microglia, the resident innate immune cell population of the brain. During AD progression, microglia shift their phenotype, and it has been suggested that they express matricellular proteins such as secreted protein acidic and rich in cysteine and Hevin protein, which facilitate the migration of other immune cells, such as blood-derived dendritic cells. We have detected both and Hevin in postmortem AD brain tissues and confirmed significant alterations in transcript expression using real-time qPCR. We suggest that an infiltration of myeloid-derived immune cells occurs in the areas of diseased tissue. duanyu1842RC is highly expressed in AD brain and collocates to Aβ protein deposits, thus contributing actively to cerebral inflammation and subsequent tissue repair, and Hevin may be downregulated in the diseased state. However, further research is needed to reveal the exact roles of duanyu1842RC and Hevin proteins and associated signaling pathways in AD-related neuroinflammation. Nevertheless, normalizing protein expression such as interdicting heightened duanyu1842RC protein expression may confer a novel therapeutic opportunity for modulating AD progression.

KEYWORDS: {{ getKeywords(articleDetailText.words) }}